Learning Objectives:

1. Understand definition N2 disease in NSCLC

2. Summarize complete phase III trials leading to current treatement strategies

3. Discuss next steps for management of N2 disease

Session date: 
09/28/2020 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jori B. Sheade, MD